Delivery Order SPE2DB22D2206-SPE2DB25FFG12
Award Date
1/26/25
Potential Completion Date
1/27/25
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award, with ID SPE2DB20D3505 and SPE2DB25FT8Z8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The $2,825.45 firm fixed-price delivery order is for the supply of 4567090879 - BUDESONIDE-FORMOTEROL 80-4.5 10.2GM, with a completion date of January 30, 2025. This award is not associated with a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT7M5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, and has a firm fixed price ceiling value of $1,350.69. The contract has a completion date of January 7, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FU0S4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $1,277.15, is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of February 26, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established...
This federal contract award, with an ID of SPE2DX15D3021|SPE2DX24F1JU9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical supply item, with a ceiling value of $1,883.20. It is a firm fixed-price delivery order contract with a completion date of February 21, 2024. The contract is not designated with a set-aside requirement,...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM4T8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4567059961 units of the pharmaceutical product BUDESONIDE-FORMOTEROL 160-4.5 10.2GM. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $26,230.01 and an ultimate completion date of January 28, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This federal contract award, with ID SPE2DB22D1017 and SPE2DB25FF5CX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,251.57 fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a medical product, with a completion date of February 11, 2025. This award is not associated with a set-aside program. The contract is part of Amerisourcebergen's larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,698.24 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has an ultimate completion date of December 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award, with ID SPE2DB20D3505|SPE2DB25FT8V2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,519.08 Firm Fixed Price Delivery Order contract is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product, with a completion date of January 28, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,278.81 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,254.91 firm fixed-price delivery order is for the supply of BUDESONIDE-FORMOTEROL 160-4.5 10.2GM, a pharmaceutical product. The contract has a completion date of January 14, 2025 and was awarded on January 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...